Proapoptotic effect of control-released basic fibroblast growth factor on skin wound healing in a diabetic mouse model.

The ability of basic fibroblast growth factor (bFGF) to improve wound healing is attenuated by its short half-life in free form. This study aimed to enhance skin wound healing in a diabetes mouse model while concomitantly decreasing scar formation using control-released bFGF together with acidic gel...

Descripción completa

Detalles Bibliográficos
Publicado en:Wound Repair & Regeneration Vol. 24; no. 1; pp. 65 - 75
Autores principales: Huang, Chenyu, Orbay, Hakan, Tobita, Morikuni, Miyamoto, Masaaki, Tabata, Yasuhiko, Hyakusoku, Hiko, Mizuno, Hiroshi
Formato: equations & formulas pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell Jan/Feb2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=113894761&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 113894761
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10671927
        DPV
      jtl: Wound Repair & Regeneration
      issn: 10671927
      maglogo: Y
    pubinfo:
      dt: Jan/Feb2016
      vid: 24
      iid: 1
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        113894761
        113894761
        113894761
        10.1111/wrr.12375
        113894761
      ppf: 65
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Proapoptotic effect of control-released basic fibroblast growth factor on skin wound healing in a diabetic mouse model.
      aug:
        au:
          Huang, Chenyu
          Orbay, Hakan
          Tobita, Morikuni
          Miyamoto, Masaaki
          Tabata, Yasuhiko
          Hyakusoku, Hiko
          Mizuno, Hiroshi
        affil: Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School, Tokyo, Japan
      sug:
        subj:
          Diabetes Mellitus
          Wound Care Methods
          Growth Substances Administration and Dosage
          Fibroblasts
          Gels Administration and Dosage
          Cicatrix Prevention and Control
          Wound Healing
          Animal Studies
          In Vivo Studies
          Mice
          Funding Source
          Histological Techniques
          Endothelium Analysis
          Neovascularization, Physiologic Evaluation
          Immunohistochemistry
          Apoptosis Evaluation
          Staining and Labeling
          Time Factors
          Delayed-Action Preparations Therapeutic Use
          Descriptive Statistics
          P-Value
          Japan
          Image Processing, Computer Assisted
          Data Analysis Software
          Mathematics
          Microscopy
          Two-Tailed Test
          Analysis of Variance
      ab: The ability of basic fibroblast growth factor (bFGF) to improve wound healing is attenuated by its short half-life in free form. This study aimed to enhance skin wound healing in a diabetes mouse model while concomitantly decreasing scar formation using control-released bFGF together with acidic gelatin hydrogel microspheres (AGHMs). Bilateral full-thickness wounds (10 mm in diameter) were made on the backs of db/db mice. Forty-five mice were divided into three groups, and the base of the wound under the panniculus carnosus and the wound periphery were injected with phosphate-buffered saline (300 μL) containing (1) controlreleased bFGF (50 μg), (2) control-released bFGF (20 μg), or (3) AGHMs alone. The size of the wound area was recorded on each postoperative day (POD). Mice were sacrificed on postoperative day 4, 7, 10, 14, and 28, and skin wound specimens were obtained to assess the endothelium/angiogenesis index via cluster of differentiation 31 immunohistochemistry, the proliferation index via Ki-67 immunohistochemistry, and the myofibroblast and fibroblast apoptosis indices by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling and alphasmooth muscle actin or vimentin staining, respectively. Epithelialization rates and indices of proliferation and myofibroblast/fibroblast apoptosis were higher in the bFGF groups than in the AGHM group, mainly within 2 weeks of injury. No dose-effect relationship was found for control-released bFGF, although the actions of 50 μg bFGF seemed to last longer than those of 20 μg bFGF. Therefore, control-released bFGF may accelerate diabetic skin wound healing and induce myofibroblast/fibroblast apoptosis, thereby reducing scar formation.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N